{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:34:44Z","timestamp":1791999284452,"version":"4.4.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","award":["IRP SystAct"],"award-info":[{"award-number":["IRP SystAct"]}],"id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["IRP AdaptAct"],"award-info":[{"award-number":["IRP AdaptAct"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["CAPES-PRINT 8888887.571313-2020-00"],"award-info":[{"award-number":["CAPES-PRINT 8888887.571313-2020-00"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007379","name":"Fondation pour l'Aide \u00e0 la Recherche sur la Scl\u00e9rose en Plaques","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007379","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-60224-3","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:19:45Z","timestamp":1751354385000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["In vitro morphological profiling of T cells predicts clinical response to natalizumab therapy in patients with multiple sclerosis"],"prefix":"10.1038","volume":"16","author":[{"given":"Beatriz","family":"Chaves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7327-4294","authenticated-orcid":false,"given":"Juan Carlo","family":"Santos e Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5297-9108","authenticated-orcid":false,"given":"Helder","family":"Nakaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Socquet-Juglard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Bucciarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilh\u00e8n","family":"Prunier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matheus V.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Lacouture","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5392-0428","authenticated-orcid":false,"given":"Saniya","family":"Kari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0144-3431","authenticated-orcid":false,"given":"Anne L.","family":"Astier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1584-7234","authenticated-orcid":false,"given":"Marco A.","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o H. M.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5477-5475","authenticated-orcid":false,"given":"Roland","family":"Liblau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6753-3480","authenticated-orcid":false,"given":"Vinicius","family":"Cotta-de-Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7278-6503","authenticated-orcid":false,"given":"Lo\u00efc","family":"Dupr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"60224_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1600-065X.1990.tb00561.x","volume":"114","author":"ME Hemler","year":"1990","unstructured":"Hemler, M. E., Elices, M. J., Parker, C. & Takada, Y. Structure of the integrin VLA-4 and its cell-cell and cell-matrix adhesion functions. Immunol. Rev. 114, 45\u201365 (1990).","journal-title":"Immunol. Rev."},{"key":"60224_CR2","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1083\/jcb.128.6.1243","volume":"128","author":"R Alon","year":"1995","unstructured":"Alon, R. et al. The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J. Cell Biol. 128, 1243\u20131253 (1995).","journal-title":"J. Cell Biol."},{"key":"60224_CR3","doi-asserted-by":"publisher","first-page":"11058","DOI":"10.1073\/pnas.0307927101","volume":"101","author":"M Mittelbrunn","year":"2004","unstructured":"Mittelbrunn, M. et al. VLA-4 integrin concentrates at the peripheral supramolecular activation complex of the immune synapse and drives T helper 1 responses. Proc. Natl Acad. Sci. USA 101, 11058\u201311063 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"60224_CR4","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.immuni.2008.04.019","volume":"28","author":"K Nguyen","year":"2008","unstructured":"Nguyen, K., Sylvain, N. R. & Bunnell, S. C. T cell costimulation via the integrin VLA-4 inhibits the actin-dependent centralization of signaling microclusters containing the adaptor SLP-76. Immunity 28, 810\u2013821 (2008).","journal-title":"Immunity"},{"key":"60224_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.humimm.2009.09.360","volume":"71","author":"TK Kim","year":"2010","unstructured":"Kim, T. K., Billard, M. J., Wieder, E. D., McIntyre, B. W. & Komanduri, K. V. Co-engagement of alpha(4)beta(1) integrin (VLA-4) and CD4 or CD8 is necessary to induce maximal Erk1\/2 phosphorylation and cytokine production in human T cells. Hum. Immunol. 71, 23\u201328 (2010).","journal-title":"Hum. Immunol."},{"key":"60224_CR6","doi-asserted-by":"publisher","first-page":"4637","DOI":"10.3390\/ijms23094637","volume":"23","author":"G Pyka-Fo\u015bciak","year":"2022","unstructured":"Pyka-Fo\u015bciak, G., Lis, G. J. & Litwin, J. A. Adhesion molecule profile and the effect of anti-VLA-4 mAb treatment in experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis. Int J. Mol. Sci. 23, 4637 (2022).","journal-title":"Int J. Mol. Sci."},{"key":"60224_CR7","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1001\/archneur.57.4.546","volume":"57","author":"I Elovaara","year":"2000","unstructured":"Elovaara, I. et al. Adhesion molecules in multiple sclerosis: relation to subtypes of disease and methylprednisolone therapy. Arch. Neurol. 57, 546\u2013551 (2000).","journal-title":"Arch. Neurol."},{"key":"60224_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nature16939","volume":"530","author":"C Schl\u00e4ger","year":"2016","unstructured":"Schl\u00e4ger, C. et al. Effector T-cell trafficking between the leptomeninges and the cerebrospinal fluid. Nature 530, 349\u2013353 (2016).","journal-title":"Nature"},{"key":"60224_CR9","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1084\/jem.20140540","volume":"211","author":"T Schneider-Hohendorf","year":"2014","unstructured":"Schneider-Hohendorf, T. et al. VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells. J. Exp. Med. 211, 1833 (2014).","journal-title":"J. Exp. Med."},{"key":"60224_CR10","doi-asserted-by":"crossref","unstructured":"Charabati, M. et al. DICAM promotes TH17 lymphocyte trafficking across the blood-brain barrier during autoimmune neuroinflammation. Sci. Transl. Med. 14, eabj0473 (2022).","DOI":"10.1126\/scitranslmed.abj0473"},{"key":"60224_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/356063a0","volume":"356","author":"TA Yednock","year":"1992","unstructured":"Yednock, T. A. et al. Prevention of experimental autoimmune encephalomyelitis by antibodies against \u03b14\u03b2l integrin. Nature 356, 63\u201366 (1992).","journal-title":"Nature"},{"key":"60224_CR12","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/med.10044","volume":"23","author":"GX Yang","year":"2003","unstructured":"Yang, G. X. & Hagmann, W. K. VLA-4 antagonists: potent inhibitors of lymphocyte migration. Med. Res. Rev. 23, 369\u2013392 (2003).","journal-title":"Med. Res. Rev."},{"key":"60224_CR13","doi-asserted-by":"crossref","unstructured":"Schwab, N. & Wiendl, H. Learning CNS immunopathology from therapeutic interventions. Sci. Transl. Med. 15, eadg7863 (2023).","DOI":"10.1126\/scitranslmed.adg7863"},{"key":"60224_CR14","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1056\/NEJMoa044397","volume":"354","author":"CH Polman","year":"2006","unstructured":"Polman, C. H. et al. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. 354, 899\u2013910 (2006).","journal-title":"N. Engl. J. Med."},{"key":"60224_CR15","doi-asserted-by":"publisher","first-page":"3302","DOI":"10.1002\/eji.201545632","volume":"45","author":"G Martin-Blondel","year":"2015","unstructured":"Martin-Blondel, G. et al. Migration of encephalitogenic CD8 T cells into the central nervous system is dependent on the \u03b14\u03b21-integrin. Eur. J. Immunol. 45, 3302 (2015).","journal-title":"Eur. J. Immunol."},{"key":"60224_CR16","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S1474-4422(09)70021-3","volume":"8","author":"E Havrdova","year":"2009","unstructured":"Havrdova, E. et al. Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the natalizumab safety and efficacy in relapsing-remitting multiple sclerosis (AFFIRM) study. Lancet Neurol. 8, 254\u2013260 (2009).","journal-title":"Lancet Neurol."},{"key":"60224_CR17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jns.2016.03.025","volume":"364","author":"L Prosperini","year":"2016","unstructured":"Prosperini, L., Fanelli, F. & Pozzilli, C. Long-term assessment of no evidence of disease activity with natalizumab in relapsing multiple sclerosis. J. Neurol. Sci. 364, 145\u2013147 (2016).","journal-title":"J. Neurol. Sci."},{"key":"60224_CR18","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jns.2011.10.005","volume":"314","author":"G Defer","year":"2012","unstructured":"Defer, G. et al. CD49d expression as a promising biomarker to monitor natalizumab efficacy. J. Neurol. Sci. 314, 138\u2013142 (2012).","journal-title":"J. Neurol. Sci."},{"key":"60224_CR19","doi-asserted-by":"crossref","unstructured":"Mu\u00f1oz, \u00da. et al. Serum levels of IgM to phosphatidylcholine predict the response of multiple sclerosis patients to natalizumab or IFN-\u03b2. Sci. Rep. 12, 13357 (2022).","DOI":"10.1038\/s41598-022-16218-y"},{"key":"60224_CR20","doi-asserted-by":"publisher","first-page":"464","DOI":"10.2174\/1871527317666180703102536","volume":"17","author":"R Balasa","year":"2018","unstructured":"Balasa, R. et al. The matrix metalloproteinases panel in multiple sclerosis patients treated with natalizumab: a possible answer to natalizumab non-responders. CNS Neurol. Disord. Drug Targets 17, 464\u2013472 (2018).","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"60224_CR21","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1001\/archneurol.2011.971","volume":"69","author":"LM Villar","year":"2012","unstructured":"Villar, L. M. et al. Immunological markers of optimal response to natalizumab in multiple sclerosis. Arch. Neurol. 69, 191\u2013197 (2012).","journal-title":"Arch. Neurol."},{"key":"60224_CR22","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jocn.2012.04.022","volume":"20","author":"J Sargento-Freitas","year":"2013","unstructured":"Sargento-Freitas, J., Batista, S., MacArio, C., Matias, F. & Sousa, L. Clinical predictors of an optimal response to natalizumab in multiple sclerosis. J. Clin. Neurosci. 20, 659\u2013662 (2013).","journal-title":"J. Clin. Neurosci."},{"key":"60224_CR23","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1056\/NEJMoa1107829","volume":"366","author":"G Bloomgren","year":"2012","unstructured":"Bloomgren, G. et al. Risk of natalizumab-associated progressive multifocal leukoencephalopathy. N. Engl. J. Med. 366, 1870\u20131880 (2012).","journal-title":"N. Engl. J. Med."},{"key":"60224_CR24","doi-asserted-by":"crossref","unstructured":"German, Y. et al. Morphological profiling of human T and NK lymphocytes by high-content cell imaging. Cell Rep. 36, 109318 (2021).","DOI":"10.1016\/j.celrep.2021.109318"},{"key":"60224_CR25","doi-asserted-by":"publisher","first-page":"5631","DOI":"10.1126\/sciadv.abn5631","volume":"8","author":"Y Severin","year":"2022","unstructured":"Severin, Y. et al. Multiplexed high-throughput immune cell imaging reveals molecular health-associated phenotypes. Sci. Adv. 8, 5631 (2022).","journal-title":"Sci. Adv."},{"key":"60224_CR26","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s43018-023-00544-9","volume":"4","author":"K Kropivsek","year":"2023","unstructured":"Kropivsek, K. et al. Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myeloma. Nat. Cancer 4, 734\u2013753 (2023).","journal-title":"Nat. Cancer"},{"key":"60224_CR27","doi-asserted-by":"publisher","unstructured":"Vicente-Manzanares, M. & S\u00e1nchez-Madrid, F. Role of the cytoskeleton during leukocyte responses. Nat. Rev. Immunol. https:\/\/doi.org\/10.1038\/nri1268 (2004).","DOI":"10.1038\/nri1268"},{"key":"60224_CR28","doi-asserted-by":"publisher","first-page":"696","DOI":"10.4049\/jimmunol.168.2.696","volume":"168","author":"SJ Hyduk","year":"2002","unstructured":"Hyduk, S. J. & Cybulsky, M. I. \u03b14 Integrin signaling activates phosphatidylinositol 3-kinase and stimulates T cell adhesion to intercellular adhesion molecule-1 to a similar extent as CD3, but induces a distinct rearrangement of the actin cytoskeleton.  J. Immunol. 168, 696\u2013704 (2002).","journal-title":"J. Immunol."},{"key":"60224_CR29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/ene.12204","volume":"21","author":"O Outteryck","year":"2014","unstructured":"Outteryck, O. et al. A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort. Eur. J. Neurol. 21, 40\u201348 (2014).","journal-title":"Eur. J. Neurol."},{"key":"60224_CR30","doi-asserted-by":"publisher","first-page":"10241","DOI":"10.1016\/S0021-9258(18)99215-X","volume":"266","author":"R Pulido","year":"1991","unstructured":"Pulido, R. et al. Functional evidence for three distinct and independently inhibitable adhesion activities mediated by the human integrin VLA-4. Correlation with distinct \u03b14 epitopes. J. Biol. Chem. 266, 10241\u201310245 (1991).","journal-title":"J. Biol. Chem."},{"key":"60224_CR31","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1158\/2159-8290.CD-21-0410","volume":"12","author":"D Malani","year":"2022","unstructured":"Malani, D. et al. Implementing a functional precision medicine tumor board for acute myeloid leukemia. Cancer Discov. 12, 388\u2013401 (2022).","journal-title":"Cancer Discov."},{"key":"60224_CR32","doi-asserted-by":"publisher","first-page":"e595","DOI":"10.1016\/S2352-3026(17)30208-9","volume":"4","author":"B Snijder","year":"2017","unstructured":"Snijder, B. et al. Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot study. Lancet Haematol. 4, e595\u2013e606 (2017).","journal-title":"Lancet Haematol."},{"key":"60224_CR33","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1158\/2159-8290.CD-21-0538","volume":"12","author":"C Kornauth","year":"2022","unstructured":"Kornauth, C. et al. Functional precision medicine provides clinical benefit in advanced aggressive hematologic cancers and identifies exceptional responders. Cancer Discov. 12, 372\u2013387 (2022).","journal-title":"Cancer Discov."},{"key":"60224_CR34","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3390\/jpm11121347","volume":"11","author":"J Granell-Geli","year":"2021","unstructured":"Granell-Geli, J. et al. Assessing blood-based biomarkers to define a therapeutic window for natalizumab. J. Pers. Med. 11, 1347 (2021).","journal-title":"J. Pers. Med."},{"key":"60224_CR35","first-page":"1","volume":"10","author":"Z Xu","year":"2022","unstructured":"Xu, Z., Guo, K., Chu, W., Lou, J. & Chen, C. Performance of machine learning algorithms for predicting adverse outcomes in community-acquired pneumonia. Front. Bioeng. Biotechnol. 10, 1 (2022).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"60224_CR36","doi-asserted-by":"publisher","unstructured":"El-Bouri, W. K., Sanders, A. & Lip, G. Y. H. Predicting acute and long-term mortality in a cohort of pulmonary embolism patients using machine learning. Eur. J. Intern. Med. https:\/\/doi.org\/10.1016\/J.EJIM.2023.07.012 (2023).","DOI":"10.1016\/J.EJIM.2023.07.012"},{"key":"60224_CR37","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adj8094","volume":"9","author":"V Kavaka","year":"2024","unstructured":"Kavaka, V. et al. Twin study identifies early immunological and metabolic dysregulation of CD8+ T cells in multiple sclerosis. Sci. Immunol. 9, eadj8094 (2024).","journal-title":"Sci. Immunol."},{"key":"60224_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102470","volume":"46","author":"A Beldi-Ferchiou","year":"2020","unstructured":"Beldi-Ferchiou, A. et al. High effector-memory CD8+ T-cell levels correlate with high PML risk in natalizumab-treated patients. Mult. Scler. Relat. Disord. 46, 102470 (2020).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"60224_CR39","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jneuroim.2015.08.010","volume":"287","author":"S Dallari","year":"2015","unstructured":"Dallari, S. et al. Upregulation of integrin expression on monocytes in multiple sclerosis patients treated with natalizumab. J. Neuroimmunol. 287, 76\u201379 (2015).","journal-title":"J. Neuroimmunol."},{"key":"60224_CR40","doi-asserted-by":"publisher","first-page":"e81685","DOI":"10.1371\/journal.pone.0081685","volume":"8","author":"J Mellerg\u00e5rd","year":"2013","unstructured":"Mellerg\u00e5rd, J. et al. Increased B cell and cytotoxic NK cell proportions and increased T cell responsiveness in blood of natalizumab-treated multiple sclerosis patients. PLoS ONE 8, e81685 (2013).","journal-title":"PLoS ONE"},{"key":"60224_CR41","doi-asserted-by":"crossref","unstructured":"Roy, N. H. et al. LFA-1 signals to promote actin polymerization and upstream migration in T cells. J. Cell Sci. 133, jcs248328 (2020).","DOI":"10.1242\/jcs.248328"},{"key":"60224_CR42","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1182\/blood.V91.7.2231","volume":"91","author":"T Papayannopoulou","year":"1998","unstructured":"Papayannopoulou, T., Priestley, G. V. & Nakamoto, B. Anti\u2013VLA4\/VCAM-1\u2014Induced mobilization requires cooperative signaling through the kit\/mkit ligand pathway. Blood 91, 2231\u20132239 (1998).","journal-title":"Blood"},{"key":"60224_CR43","doi-asserted-by":"publisher","unstructured":"Ley, K., Rivera-Nieves, J., Sandborn, W. J. & Shattil, S. Integrin-based therapeutics: biological basis, clinical use and new drugs. Nat. Rev. Drug Discov. https:\/\/doi.org\/10.1038\/nrd.2015.10 (2016).","DOI":"10.1038\/nrd.2015.10"},{"key":"60224_CR44","doi-asserted-by":"crossref","unstructured":"Dupr\u00e9, L., Houmadi, R., Tang, C. & Rey-Barroso, J. T lymphocyte migration: an action movie starring the actin and associated actors. Front. Immunol. 6, 586 (2015).","DOI":"10.3389\/fimmu.2015.00586"},{"key":"60224_CR45","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1083\/jcb.201107140","volume":"197","author":"J Rullo","year":"2012","unstructured":"Rullo, J. et al. Actin polymerization stabilizes \u03b14\u03b21 integrin anchors that mediate monocyte adhesion. J. Cell Biol. 197, 115\u2013129 (2012).","journal-title":"J. Cell Biol."},{"key":"60224_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40537-021-00444-8","volume":"8","author":"L Alzubaidi","year":"2021","unstructured":"Alzubaidi, L. et al. Review of deep learning: concepts, CNN architectures, challenges, applications, future directions. J. Big Data 8, 1\u201374 (2021).","journal-title":"J. Big Data"},{"key":"60224_CR47","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1001\/jamaneurol.2023.1135","volume":"80","author":"M Hittle","year":"2023","unstructured":"Hittle, M. et al. Population-based estimates for the prevalence of multiple sclerosis in the United States by race, ethnicity, age, sex, and geographic region. JAMA Neurol. 80, 693\u2013701 (2023).","journal-title":"JAMA Neurol."},{"key":"60224_CR48","doi-asserted-by":"crossref","unstructured":"Havrdova, E., Galetta, S., Stefoski, D. & Comi, G. Freedom from disease activity in multiple sclerosis. Neurology 74, S3\u2013S7 (2010).","DOI":"10.1212\/WNL.0b013e3181dbb51c"},{"key":"60224_CR49","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa, F. et al. Scikit-learn: machine learning in Python. J. Mach. Learn. Res. 12, 2825\u20132830 (2011).","journal-title":"J. Mach. Learn. Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60224-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60224-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60224-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:19:48Z","timestamp":1751354388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60224-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["60224"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-60224-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4536459\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"5 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5533"}}